| 日期 | 代号 | 名称 | 回购股数 | 金额 | 回购价 最高 最低 |
回购股数 (年初至今) |
占已发行股本(%) | |
| 20/09/2024 | 01797 | 东方甄选 | 124,000 | HKD 1,570,230 | HKD 12.720 | HKD 12.240 | 2,877,000 | 0.284 |
| 20/09/2024 | 02196 | 复星医药 | 314,900 | RMB 6,999,427 | RMB 22.380 | RMB 22.110 | -- | -- |
| 20/09/2024 | 00546 | 阜丰集团 | 1,000,000 | HKD 4,268,870 | HKD 4.300 | HKD 4.240 | 4,699,000 | 0.186 |
| 20/09/2024 | 02238 | 广汽集团 | 432,000 | HKD 1,013,880 | HKD 2.350 | HKD 2.340 | 131,370,000 | 4.240 |
| 20/09/2024 | 00393 | 旭日企业 | 100,000 | HKD 100,000 | HKD 1.000 | HKD 1.000 | 5,840,000 | 0.386 |
| 20/09/2024 | 02273 | 固生堂 | 129,700 | HKD 4,549,730 | HKD 35.550 | HKD 34.750 | 2,036,500 | 0.831 |
| 20/09/2024 | 06826 | 昊海生物科技 | 7,000 | HKD 211,000 | HKD 30.250 | HKD 30.100 | 1,225,600 | 4.141 |
| 20/09/2024 | 02142 | 和铂医药－Ｂ | 70,000 | HKD 86,720 | HKD 1.250 | HKD 1.230 | 820,000 | 0.107 |
| 20/09/2024 | 06886 | HTSC | 2,082,559 | RMB 15,377,474 | RMB 8.070 | RMB 7.370 | -- | -- |
| 20/09/2024 | 06078 | 海吉亚医疗 | 10,600 | HKD 163,240 | HKD 15.400 | HKD 15.400 | 5,556,200 | 0.880 |
| 20/09/2024 | 06127 | 昭衍新药 | 35,000 | RMB 472,500 | RMB 13.500 | RMB 13.500 | -- | -- |
| 20/09/2024 | 09997 | 康基医疗 | 20,000 | HKD 106,426 | HKD 5.370 | HKD 5.240 | 5,209,000 | 0.429 |
| 20/09/2024 | 03650 | KEEP | 50,000 | HKD 289,256 | HKD 5.880 | HKD 5.680 | 3,497,600 | 0.665 |
| 20/09/2024 | 01024 | 快手－Ｗ | 1,477,800 | HKD 61,170,137 | HKD 41.750 | HKD 40.750 | 53,096,900 | 1.224 |
| 20/09/2024 | 01513 | 丽珠医药 | 300,000 | RMB 10,610,180 | RMB 35.550 | RMB 35.160 | -- | -- |
| 20/09/2024 | 06667 | 美因基因 | 25,000 | HKD 198,830 | HKD 7.980 | HKD 7.930 | 1,946,800 | 0.824 |
| 20/09/2024 | 02282 | 美高梅中国 | 419,700 | HKD 4,291,980 | HKD 10.340 | HKD 10.180 | 7,996,200 | 0.210 |
| 20/09/2024 | 02172 | 微创脑科学 | 250,000 | HKD 1,983,880 | HKD 8.000 | HKD 7.810 | 500,000 | 0.090 |
| 20/09/2024 | 02235 | 微泰医疗－Ｂ | 37,700 | HKD 133,359 | HKD 3.560 | HKD 3.470 | 1,034,600 | 0.595 |
| 20/09/2024 | 00909 | 明源云 | 315,000 | HKD 587,707 | HKD 1.860 | HKD 1.860 | 26,967,000 | 1.371 |
| 20/09/2024 | 09896 | 名创优品 | 122,268 | HKD 3,882,677 | HKD 31.766 | HKD 31.707 | 5,667,344 | 0.450 |
| 20/09/2024 | 00947 | 摩比发展 | 12,000 | HKD 1,680 | HKD 0.140 | HKD 0.140 | 1,966,000 | 0.244 |
| 20/09/2024 | 02343 | 太平洋航运 | 2,104,000 | HKD 4,363,906 | HKD 2.080 | HKD 2.040 | 89,384,000 | 1.698 |
| 20/09/2024 | 01358 | 普华和顺 | 3,020,000 | HKD 3,465,200 | HKD 1.160 | HKD 1.140 | 35,553,000 | 2.271 |
| 20/09/2024 | 02498 | 速腾聚创 | 50,000 | HKD 685,920 | HKD 13.720 | HKD 13.640 | 9,289,400 | 2.060 |
| 20/09/2024 | 01910 | 新秀丽 | 1,150,800 | HKD 21,400,967 | HKD 19.000 | HKD 18.380 | 26,170,500 | 1.791 |
| 20/09/2024 | 00338 | 上海石油化工股份 | 7,452,000 | HKD 7,795,537 | HKD 1.060 | HKD 1.040 | 24,754,000 | 0.713 |
| 20/09/2024 | 00697 | 首程控股 | 18,000 | HKD 24,798 | HKD 1.370 | HKD 1.370 | 12,824,000 | 0.176 |
| 20/09/2024 | 02096 | 先声药业 | 610,000 | HKD 3,786,870 | HKD 6.250 | HKD 6.170 | 30,309,000 | 1.161 |
| 20/09/2024 | 00386 | 中国石油化工股份 | 23,200,000 | HKD 104,655,200 | HKD 4.570 | HKD 4.470 | 67,488,000 | 0.060 |
| 20/09/2024 | 00386 | 中国石油化工股份 | 500,000 | RMB 3,182,000 | RMB 6.380 | RMB 6.310 | -- | -- |
| 20/09/2024 | 02386 | 中石化炼化工程 | 288,000 | HKD 1,486,252 | HKD 5.180 | HKD 5.110 | 5,835,500 | 0.400 |
| 20/09/2024 | 00751 | 创维集团 | 2,016,000 | HKD 5,724,432 | HKD 2.840 | HKD 2.830 | 77,478,000 | 3.280 |
| 20/09/2024 | 01426 | 春泉产业信托 | 27,000 | HKD 52,069 | HKD 1.930 | HKD 1.910 | 540,000 | 0.040 |
| 20/09/2024 | 02005 | 石四药集团 | 1,800,000 | HKD 6,881,120 | HKD 3.900 | HKD 3.780 | 11,084,000 | 0.373 |
| 20/09/2024 | 00019 | 太古股份公司Ａ | 304,000 | HKD 19,233,380 | HKD 63.750 | HKD 62.500 | 16,582,000 | 1.986 |
| 20/09/2024 | 00087 | 太古股份公司Ｂ | 187,500 | HKD 1,860,750 | HKD 9.970 | HKD 9.760 | 20,750,000 | 0.716 |
| 20/09/2024 | 01972 | 太古地产 | 456,000 | HKD 6,760,564 | HKD 14.900 | HKD 14.580 | 7,656,000 | 0.131 |
| 20/09/2024 | 00700 | 腾讯控股 | 2,580,000 | HKD 1,002,917,982 | HKD 393.000 | HKD 383.800 | 165,520,000 | 1.757 |
| 20/09/2024 | 06868 | 天福 | 5,000 | HKD 19,470 | HKD 3.900 | HKD 3.880 | 150,000 | 0.014 |
| 1 2 3 4 5 6 7 8 9 10 | ||||||||